BIRC5 and neoplasm: The aim is to provide an authoritative account and new insight into the research progress in recent years on the use of different polymer-based nano-platforms for tumor-targeted survivin siRNA delivery (Figure 1), thereby bridging the gap between preclinical studies and clinical applications in nanomedicine.